India offers expert, evidence-based treatment for Malignant Mesothelioma, a rare but aggressive cancer linked to asbestos exposure. With specialists like Dr. Ankur Bahl, India provides surgery, chemotherapy, and immunotherapy at costs ranging from $5,000 to $11,000, depending on stage and type. In comparison, the same care costs $50,000–$90,000 in the USA and $20,000–$35,000 in Thailand. India’s global-quality care at 70–80% lower cost makes it a top destination for international patients.
Malignant mesothelioma is a rare and aggressive cancer affecting the mesothelial lining of major organs such as the lungs, abdomen, heart, or testicles. It is primarily caused by prolonged exposure to asbestos fibers, often occurring in workers from industries like construction, shipbuilding, and mining.
Mesothelioma has a long latency period — typically 20–50 years post-exposure — which means symptoms appear decades after contact with asbestos. The cancer is known for being highly invasive and usually requires a multimodal approach to treatment, including surgery, chemotherapy, radiation, and immunotherapy.
Understanding the type and histology is crucial in selecting the right treatment plan.
Symptoms vary by mesothelioma type, but common indicators include:
India’s cancer centers offer all these tests under one roof with quick turnaround time and internationally validated lab standards.
India follows a multimodal approach, combining surgery, chemotherapy, radiation, and supportive care for improved survival.
Performed only if the disease is resectable and lung/organ function is intact:
India’s top cancer hospitals are equipped with advanced technologies, offering diagnostic and treatment capabilities on par with international standards:
These tools contribute to high diagnostic accuracy, better surgical outcomes, and fewer complications.
India has emerged as a leading global destination for cancer treatment. Here’s why foreign patients trust India:
Dr. Ankur Bahl is a leading oncologist in India, recognized for his expertise in rare cancers like malignant mesothelioma.
|
Treatment Component |
Estimated Cost (USD) |
|
Consultations & Lab Tests |
$300 – $500 |
|
Biopsy + Immunohistochemistry |
$500 – $900 |
|
PET-CT / MRI Imaging |
$800 – $1,200 |
|
Surgery (EPP or P/D) |
$2,500 – $4,500 |
|
Chemotherapy (4–6 cycles) |
$2,000 – $3,000 |
|
Immunotherapy (per cycle) |
$2,000 – $5,000 |
|
Radiation Therapy |
$1,200 – $2,000 |
|
Hospital Stay (5–10 days) |
$600 – $1,000 |
|
Total Estimated Range |
$5,000 – $11,000 |
|
Country |
Estimated Total Cost (USD) |
|
India |
$5,000 – $11,000 |
|
Thailand |
$20,000 – $35,000 |
|
USA |
$50,000 – $90,000 |
India saves up to 80% while offering comparable or even better care outcomes.
Here's how international patients typically receive care in India:
India is a world-class destination for malignant mesothelioma treatment, providing global-standard care at a fraction of Western costs. With expert oncologists like Dr. Ankur Bahl, advanced technology, comprehensive support services, and affordable pricing, international patients receive timely, life-extending treatment without compromising on quality.
Whether it’s surgery, chemotherapy, immunotherapy, or radiation, India offers hope and healing for mesothelioma patients worldwide.
Mesothelioma is rarely curable, but early-stage patients undergoing surgery and systemic therapy can achieve long-term survival. For advanced cases, immunotherapy can prolong life and improve quality.
With multimodal therapy, survival ranges from 12 to 36 months. Patients with epithelioid type and early diagnosis have better outcomes.
Yes. Drugs like nivolumab and ipilimumab have shown significant response rates, especially in unresectable or PD-L1–positive cases.
Yes. High-risk thoracic surgeries like EPP or P/D are performed by experienced thoracic surgeons using advanced ICU support, robotic platforms, and post-op rehab.
Yes. India offers FDA/EMA-approved drugs, including pemetrexed, cisplatin, nivolumab, and pembrolizumab.
Yes, once stable. You’ll be provided a fitness-to-fly certificate after discharge and support during travel.
Absolutely. Many top Indian hospitals are NABH and JCI accredited and follow global patient safety protocols.
Some hospitals accept international insurance and offer reimbursement documentation. You should confirm coverage before travel.